A novel simple method using liquid chromatography/ time-of-flight mass spectrometry (LC/TOF-MS) and LC/UV was established for the quantification of saponins in an extract from green tea leaves. The amount of saponins in a fraction with high in vitro antihypercholesterolemic activity, Fr2-3, was determined to be 72%. An in vivo experiment showed that the addition of 0.5% Fr2-3 to a high-cholesterol diet suppressed the increase in serum cholesterol levels in rats. Fr2-3 induced a decrease in the liver cholesterol and triglyceride levels and an increase in the fecal excretion of cholesterol. These results indicate tea-leaf saponins to be the active components in Fr2-3 and that these saponins exhibited antihypercholesterolemic activity by inhibiting cholesterol absorption in the intestines.
Saponin is a steroid or triterpene glycoside found in a variety of plants. In green tea leaves, several saponins such as theasaponin B 1 , 1) assamsaponin J, 2) isotheasaponin B 1 -B 3 , 3) foliatheasaponin I-V, 4) and floratheasaponin A 4) have already been identified. In pharmacological studies on tea-leaf saponins, neutrophil-stimulating, 5) antimicrobial, 6) anti-inflammatory, 6) antihypertensive, 7) and anti-allergic 8) effects have been reported. We have previously reported that a catechin-free saponin-rich extract from green tea leaves (TE) suppressed dietinduced hypercholesterolemia in rats. 9) Tea-leaf saponins were presumed to be the active components of TE, because certain types of saponins were earlier reported to have antihypercholesterolemic activity. 10) We then fractionated TE and performed an in vitro experiment to determine the antihypercholesterolemic activity of each fraction and identify the active components in TE. 11) Liquid chromatography/time-of-flight mass spectrometry (LC/TOF-MS) was used to find that the active fraction, Fr2-3, in the in vitro study mostly contained saponins. However, the in vivo effect of Fr2-3 and the amount of saponins in Fr2-3 still remained to be clarified.
Saponins have been qualitatively detected by their hemolytic activity. However, their quantitative determination has been difficult without using their purified standards. As saponins do not have any characteristic functional group that can react with a coloring agent, it is difficult to determine their amount by colorimetry. The conventional method to identify and quantify them has been an LC/UV assay, in which their retention times (RT) and peak areas are compared with those of purified saponin standards. It is difficult to assign the saponin peaks without these standards. However, as there are usually dozens of saponins in a plant, it is difficult to obtain all the standards and to estimate the total amount of saponins.
The saponins in tea leaves that have so far been identified contain theasapogenol B as an aglycone, and most of them contain a cinnamoyl group as a functional group. [1] [2] [3] [4] We considered that the fragment peak of theasapogenol B measured by LC/TOF-MS could be used to identify the saponins and that the absorption at 280 nm of the cinnamoyl group measured by LC/UV could be used to quantify them.
After estimating the amount of saponins in Fr2-3 by the method established in this study, we determined if Fr2-3 could suppress an increase in the serum cholesterol levels in rats with induced hypercholesterolemia.
Materials and Methods
Materials. Tea leaves (Camellia sinensis var. sinensis) were obtained in the dried form. The ingredients of the experimental diets for the rats were purchased from Oriental Yeast Co. (Tokyo, Japan). All the other reagents used were of the highest grade available from a commercial source.
Preparation of TE and its fractions. TE was prepared as reported previously. 9) Prepared TE (13.5 g) was subjected to ODS column chromatography (Cosmosil 140 C 18 -OPN, Nacalai Tesque, Kyoto, y To whom correspondence should be addressed. Tel: +81-47-305-1408; Fax: +81-47-305-1423; E-mail: matsui.yoko.2000@ogawa.net Abbreviations: TE, catechin-free saponin-rich extract of green tea leaves; LC/TOF-MS, liquid chromatography/time-of-flight mass spectrometry; RT, retention time; HC, high-cholesterol diet; HC-Fr2-3, high-cholesterol diet with addition of Fr2-3 Japan) and eluted with 40%, 80%, and 100% MeOH to give Fr1 (40% MeOH fraction, 4.4 g), Fr2 (80% MeOH fraction, 6.9 g), and Fr3 (100% MeOH fraction, 1.5 g).
Fr2 was purified by preparative HPLC based on the following isolation scheme for tea-leaf saponin isotheasaponin B 1 :
3) column, Develosil ODS-HG-5 (20 Â 250 mm, Nomura Chemical Co., Aichi, Japan); column oven temperature, room temperature; flow rate, 5 ml/min; and detection, UV 280 nm. The preparative HPLC separation of Fr2 (acetonitrile:0.05% aqueous TFA = 55:45) yielded Fr A. Fr A was further purified by preparative HPLC (MeOH:0.05% aqueous TFA = 75:25) to give the saponin-standard fraction. This saponinstandard fraction was used as a saponin standard to obtain a calibration curve for quantification.
Fr2 (6.9 g) was purified by preparative HPLC under the following conditions: column, Chromatorex-ODS (20 Â 250 mm, Fuji Silysia Chemical, Aichi, Japan); mobile phase, acetonitrile:0.05% aqueous TFA = 40:60-60:40 for 15 min, then holding at 100% acetonitrile for 15 min; column oven temperature, room temperature; and flow rate, 10 ml/min. The preparative HPLC separation of Fr2 yielded Fr2-1 (RT = 5-12.5 min, 1.9 g), Fr2-2 (RT = 12.5-15 min, 0.4 g), and Fr2-3 (RT = 15-30 min, 3.8 g).
LC/UV analysis. HPLC was performed by a Agilent 1100 series instrument under the following conditions: column, Zorbax Eclipse XDB-C18 column (Agilent, 3:0 mm Â 100 mm); mobile phase, acetonitrile:H 2 O (pH adjusted to 2.5 with phosphoric acid) = 10:90 to 100:0 in 50 min; column oven temperature, 40 C; flow rate, 1 ml/min; and detection, UV 280 nm.
LC/TOF-MS analysis. LC/TOF-MS was performed by an Aquity UPLC system coupled to an LCT premier (Nihon Waters, Tokyo, Japan). LC separation was carried out under the following conditions: column, Aquity UPLC BEH C 18 (2:1 mm Â 100 mm, Waters); mobile phase, acetonitrile:0.1% aqueous formic acid = 10:90-100:0 in 50 min; column oven temperature, 40 C; and flow rate, 0.5 ml/min. The TOF-MS system was initially calibrated with sodium formate, and the analysis was then carried out under the following conditions: electrospray positive mode; MS capillary voltage, 3000 V; sample cone, 50 V; source temperature, 100 C; cone gas flow, 50 l/h; desolvation gas temperature, 350 C; desolvation gas flow, 800 l/h; internal reference, leucine enkephalin protonated peak at m=z 556.2771; and scan, m=z 250-1500 at a rate of 0.5 s/scan.
In vivo experiment. Animal experiments were performed in accordance with the Guidelines for Animal Experiments of the College of Bioresource Sciences, Nihon University. Male Wistar rats at the age of 5 weeks (Nippon Bio-Supp Center, Tokyo, Japan) were fed on a commercial diet (CE-2, Clea Japan, Tokyo, Japan) for 1 week before the experiment. The room temperature was maintained at 23 AE 2 C with a 12-h cycle of light (08:00-20:00) and darkness. All rats were individually housed in metal cages. After the adaptation period, the rats were divided into 2 groups of 7-8 rats each on the basis of body weight; one was fed with a high-cholesterol diet (HC) and the other with a high-cholesterol diet with the addition of Fr2-3 (HC-Fr2-3). The composition of the experimental diet recommended by the American Institute of Nutrition 12) is shown in Table 1 . During the experimental period, the same amounts of diet (20 g/rat) were consumed by each group. Tap water was provided ad libitum. Body weight and food intake were recorded every day. On days 0 and 5, the rats were anesthetized with diethyl ether. Blood was collected from the tail vein, and the serum was prepared by centrifugation (450 Â g, 23 C, 15 min). On day 10, after having been fasted for 14 h, the rats were anesthetized with pentobarbital. Blood was collected from the inferior vena cava, and the serum was prepared by centrifugation (450 Â g, 23 C, 15 min). The serum and liver samples were stored at À80 C. Feces were collected from days 8 to 10. After having been dried in vacuo, they were weighed, pulverized with a pestle, and stored at -20 C.
Lipid analysis. The serum total cholesterol levels on days 0 and 5 were determined by using a Cholesterol E-Test Wako kit (Wako Pure Chemical Industries, Osaka, Japan). The serum total cholesterol, HDLcholesterol, and triglyceride levels on day 10 were determined by using a SPOT-CHEM automatic clinical chemical analyzer (Arkray, Kyoto, Japan). The liver lipids were extracted by the method of Folch et al.
13)
The cholesterol and triglyceride levels were determined with a Cholesterol E-Test Wako kit and Triglyceride Test Wako kit, respectively (Wako Pure Chemical Industries, Osaka, Japan). The fecal cholesterol and bile acids were extracted as previously described, 14) and their levels determined with the Cholesterol E-Test Wako kit and Bile Acid Test Wako kit, respectively (Wako Pure Chemical Industries, Osaka, Japan).
Statistical analysis. The results are expressed as the mean AE S.E. Statistical significance between the values for the HC and HC-Fr2-3 groups was evaluated by an unpaired Student's t-test.
Results and Discussion
We used in this investigation a saponin-standard fraction, which had been obtained after repeated preparative HPLC based on the isolation scheme for isotheasaponin B 1 , as a saponin standard for the calibration curve. Although the saponin-standard fraction contained several compounds (Fig. 1A-C) , we assumed that almost all of the compounds present in the saponin-standard fraction were saponins for the following reasons: i) The peak patterns in the total ion chromatogram (Fig. 1A) almost coincided with those of the extracted mass chromatogram at m=z 419:331 AE 0:004 (Fig. 1B) and the chromatogram at UV 280 nm (Fig. 1C) , indicating that components in the saponinstandard fraction contained theasapogenol B and a cinnamoyl group in their structure. The reason why the fragment ion at m=z 419.331 was chosen to detect theasapogenol B is because that at m=z 419.331 was more prominent than that at m=z 401.321 in every mass spectrum of the saponin-standard fraction ( Fig. 2A-D) . The fragment ion at m=z 419.331 corresponds to that of theasapogenol B with one -OH group in the -OR 1-4 groups and without having three other -OR 1-4 groups. The fragment ion at m=z 401.321 corresponds to that of theasapogenol B with no -OR 1-4 groups. Since all the saponins identified so far had one or two -OH groups in the -OR 1-4 groups, the fragment ion at m=z 419.331 would have been more strongly detected than that at m=z 401.321. However, the fragment ion at m=z 401.321 can also be used to detect theasapogenol B. ii) Since the tealeaf saponins so far reported had the same sapogenin (theasapogenol B) but slightly different combinations of sugars and acyl groups in their sapogenin moiety, their polarity could be expected to be close to each other and they would be detected in the vicinity of other saponins.
iii) The molecular formulas of 7 components in the saponin-standard fraction estimated by the LC/TOF-MS analysis ( Figure 3 shows a calibration curve for saponins obtained by the LC/UV analysis of the saponin-standard fraction at 280 nm. The reason why an LC/UV analysis was used for quantification is because the values for the peak area obtained by an LC/TOF-MS analysis often change due to ion suppression, the condition of the instruments, and differences in ionization efficacy. Figure 4 shows the total ion chromatogram, mass chromatogram at m=z 419.331 and LC/UV chromatogram at 280nm measured for Fr2-3. From the mass chromatogram at m=z 419.331 (Fig. 4B) , the peaks at RT 18-25 min were assumed to be those of saponins. The peak patterns of the mass chromatogram almost coincided with those of the LC/UV chromatogram at 280 nm (Fig. 4C ) except for only one peak at RT = 18.8 min, indicating that the saponins in Fr2-3, except for the one at RT = 18.8, had a cinnamoyl group in their structure. As several peaks that were not detected in the mass chromatogram and LC/UV chromatogram were observed at RT 30-40 min in the total ion chromatogram (Fig. 4A ), Fr2-3 would have contained components other than saponins. The values for peak areas obtained by the LC/UV analysis (Fig. 4C) were converted into the equivalent weight of the saponin-standard fraction (saponin-standard-fraction eq.) by using the calibration curve in Fig. 3 . The amount of saponins in Fr2-3 was calculated to be 3430 ng of saponin-standard-fraction eq. As the entire amount of components in Fr2-3 injected into the HPLC apparatus was 4760 ng, the saponin content in Fr2-3 was estimated to be 72%. When the calibration curve for saponins obtained from the mass chromatogram of the saponinstandard fraction was used (data not shown), the saponin content in Fr2-3 was calculated to be 64%. The reason why this value is lower than that estimated by the LC/UV analysis would be because the ionization efficacy of the saponins by the LC/TOF-MS analysis was lower than 100% and not all of the saponins were ionized in each mass-chromatogram peak.
There are two problems with the accuracy of this method. i) The saponins lacking a cinnamoyl group cannot be taken into account for quantification by this method. Scince there was one saponin without a cinnamoyl group (the peak at RT = 18.8 min) in Fr2-3, the amount of saponins would be estimated to be slightly lower than the actual amount. ii) Since the saponinstandard fraction was a mixture of saponins, the amount of saponins is expressed in terms of ''the equivalent weight of the saponin-standard fraction,'' and saponins A, peak number 2; B, peak number 4; C, peak number 7; D, peak number 8. Peak numbers correspond to those in Fig. 1 . # shows the fragment ion at m=z 401.321, and Ã shows the fragment ion at m=z 419.331. Ã Peak numbers correspond to those in Fig. 1C .
having a molecular weight considerably different from that in the saponin-standard fraction cannot be evaluated by this method. However, the molecular weight of ca. 95% of saponins in the saponin-standard fraction detected at RT = 18-25 min was between 1222 and 1320, and that of tea-leaf saponins that have already been identified was between 1216 and 1320. Moreover, most saponin peaks in Fr2-3 were detected at RT = 18-25 min. Therefore, the molecular weight of the saponins in Fr2-3 would be similar to that of saponins in the Each value is the mean AE S.E. n ¼ 7{8. , body weight of HC rats; , body weight of HC-Fr2-3 rats; , food intake of HC rats; , food intake of HC-Fr2-3 rats.
saponin-standard fraction. The amount of saponins in Fr2-3 obtained with the calibration curve of the saponinstandard fraction is thus reasonably accurate. Scince it is difficult to obtain all of the saponin standards, the method established in this study is a simple and promising way to quantify the total saponin content in a plant.
We next examined the effect of Fr2-3 on diet-induced hypercholesterolemia in rats. During the entire period, there were no significant differences in food intake or body weight between the two groups (Fig. 5) . The serum cholesterol level increased with the high-cholesterol diet, but this increase was suppressed by Fr2-3 intake (Fig. 6 ). Fr2-3 significantly lowered the total cholesterol and triglyceride levels in the liver. The excretion of cholesterol into the feces was increased with the Fr2-3 intake (Table 4) . These results indicate that Fr2-3, as in the case of TE, 9) exhibited antihypercholesterolemic activity, probably by preventing the absorption of cholesterol in the intestines.
The amount of saponins in TE was estimated to be 35% by the method already mentioned (data not shown), whereas that of saponins in Fr2-3 was 72%. In our previous study, the addition of 1% TE to a high-cholesterol diet suppressed the serum cholesterol levels.
9) The degree of suppression by the addition of 1% TE was similar to that obtained by the addition of 0.5% Fr2-3, which indicates saponins to be the active components in TE. Each value is the mean AE S.E. n ¼ 7{8. , HC rats; , HC-Fr2-3 rats.
ÃÃ significantly different at p < 0:01 from the values for HC rats on the same day. Each value is the mean AE S.E. n ¼ 7{8. Ã significantly different from the values for HC rats at p < 0:05.
ÃÃ significantly different from the values for HC rats at p < 0:01.
In conclusion, we designed a simple method to estimate the total amount of saponins in a fraction from tea leaves by using LC/TOF-MS and LC/UV, and estimated the amount of saponin in Fr2-3 to be 72%. In vivo tests showed that enriching the amount of saponins in an extract enhanced the antihypercholesterolemic efficacy, implying that tea-leaf saponins have antihypercholesterolemic activity.
